Keep Me Logged In
Stefan Dobocky, board member at DSM, says that by merging its pharma division with drug maker Patheon, a "global leader" will be created, and explains that the new entity will be run as a separate company.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by